Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators

被引:5
|
作者
Lemini, Riccardo [1 ]
Vico, Tamara Diaz [1 ]
Trumbull, Denslow A. [2 ]
Attwood, Kristopher [3 ]
Spaulding, Aaron C. [4 ]
Elli, Enrique F. [1 ]
Colibaseanu, Dorin T. [1 ]
Kukar, Moshim [5 ]
Gabriel, Emmanuel [1 ]
机构
[1] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Roswell Park Comprehens Canc Ctr, Dept Biostat, Buffalo, NY USA
[4] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[5] Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA
关键词
Esophageal cancer; overall survival (OS); calculator; nomogram; neoadjuvant chemoradiation; BODY-MASS INDEX; NEOADJUVANT CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; PREDICTS SURVIVAL; COLON-CANCER; LYMPH-NODES; SURGERY; ADENOCARCINOMA; NOMOGRAM; CHEMORADIATION;
D O I
10.21037/jgo-20-337
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Determining the best approach for esophageal cancer and predicting accurate prognosis are critical. Multiple studies evaluated characteristics associated with overall survival, and several prediction models have been developed. This study aimed to evaluate existing models and perform external validation of selected models. Methods: A retrospective investigation of a multi-site institutional enterprise for patients with a diagnosis of esophageal cancer between 2013-2014 was performed. Selected survival prediction models included the Roswell Park Comprehensive Cancer Center (RPCCC) calculator, Oregon Health & Science University (OHSU) calculator, and two nomograms published by Shapiro et al. and Sun et al. One-year overall survival, level of agreement, and performance for each model were evaluated. Results: A total of 104 patients were included and used to assess the prediction models. One-year overall survival was 0.76. Different calculators tended to rank patients similarly; however, they did not agree on predicted overall survival. The least disparity in correlation was observed between OHSU and Shapiro calculators. Shapiro's model achieved the highest performance [area under the curve (AUC) =0.63]. Conclusions: Selected models showed fair results in estimating individual overall survival, although none achieved a high performance. While these tools may support the decision-making process for esophageal cancer patients, their implementation in clinical practice requires improved refinement to optimize their clinical utility.
引用
收藏
页码:1963 / 1972
页数:10
相关论文
共 50 条
  • [31] Prognostic factors after postoperative radiotherapy in stage I-III uterine carcinosarcomas
    Rovirosa, A.
    Ascaso, C.
    Arenas, M.
    Rios, I.
    Del Pino, M.
    Ordi, J.
    Morales, J.
    Gascon, M.
    Pahisa, J.
    Biete, A.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S40 - S40
  • [32] OUTCOMES FROM A SINGLE INSTITUTION COHORT OF 248 PATIENTS WITH STAGE I-III ESOPHAGEAL CANCER TREATED WITH RADIOTHERAPY
    Lavergne, Carrie
    Niglas, Mark
    Fulton, Abrielle
    Youssef, Andrew
    Fathima, Ayesha
    Youssef, Youssef
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S27 - S27
  • [33] The Association of Change in Weight During Radiotherapy Treatment With Clinical Outcomes in Patients With Stage I-III Esophageal Cancer
    Youssef, Andrew
    Lavergne, Carrie
    Niglas, Mark
    N. G.Humphreys, Deanna
    Fulton, Abrielle
    Fathima, Ayesha
    Youssef, Youssef
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2024, 76 (04): : 356 - 363
  • [34] Outcomes from a single institution cohort of 248 patients with stage I-III esophageal cancer treated with radiotherapy: Comparison of younger and older populations
    Lavergne, Carrie
    Youssef, Andrew
    Niglas, Mark
    Humphreys, Deanna Ng
    Youssef, Youssef
    TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY, 2024, 31
  • [35] The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment
    Wen, Jiahuai
    Ye, Feng
    Li, Shuaijie
    Huang, Xiaojia
    Yang, Lu
    Xiao, Xiangsheng
    Xie, Xiaoming
    PLOS ONE, 2015, 10 (11):
  • [36] Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma
    Lu, Yanwei
    Xu, Chenwang
    Wang, Haitao
    Song, Tao
    Wu, Shixiu
    Liang, Xiaodong
    Xu, Hong'en
    FRONTIERS IN MEDICINE, 2021, 8
  • [37] Patterns of care and prognostic evaluation for stage I-III upper esophageal squamous cell carcinoma: a population-based study
    Chen, Dongbo
    Zha, Xiaozhu
    Ye, Dongmei
    Kang, Mei
    Zhu, Liyang
    Yang, Mingwei
    Chen, Yu
    Zhu, Kechao
    Xia, Wanli
    Wang, Zhi
    Wang, Yichun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [38] Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery
    Kamada, Teppei
    Haruki, Koichiro
    Nakashima, Keigo
    Takahashi, Junji
    Nakaseko, Yuichi
    Suzuki, Norihiko
    Ohdaira, Hironori
    Eto, Ken
    Ikegami, Toru
    Suzuki, Yutaka
    SURGERY TODAY, 2023, 53 (9) : 1064 - 1072
  • [39] Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
    Schulze, Arik Bernard
    Schmidt, Lars Henning
    Heitkoetter, Birthe
    Huss, Sebastian
    Mohr, Michael
    Marra, Alessandro
    Hillejan, Ludger
    Goerlich, Dennis
    Barth, Peter J.
    Rehkaemper, Jan
    Evers, Georg
    THORACIC CANCER, 2020, 11 (01) : 120 - 129
  • [40] Prognostic Effect of Inflammatory Genes on Stage I-III Colorectal Cancer-Integrative Analysis of TCGA Data
    Choe, Eun Kyung
    Lee, Sangwoo
    Kim, So Yeon
    Shivakumar, Manu
    Park, Kyu Joo
    Chai, Young Jun
    Kim, Dokyoon
    CANCERS, 2021, 13 (04) : 1 - 14